ORGEN OSTEO CARE
Natural health product licensed in Canada
- Other names
- Bioway Cartifix, Bioway Cartigo, Gayatri Ayurveda Orthotone, Osteo Care, Vasishta Ayurvedic Osteo Care
- Licence holder
- Biowell Laboratories
- NPN or DIN-HM
- 80096190
- Status
- Active licence
- Licence date
- 18 December 2019
- Revision date
- 22 November 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Glucosamine sulfate | 375 mg | Not calculated |
| Sulfate de 2-Amino-2-désoxy-D-glucose Source : Chlorure de potassium | 375 mg | Not calculated |
| Sulfate de chondroïtine Source : Sulfate de chondroïtine | 75 mg | Not calculated |
| Méthylsulfonylméthane Source : Sulfone de diméthyl | 37.5 mg | Not calculated |
| Trigonella foenum-graecum Source : Graine(s) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 375 mg | 37.5 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 2 Tous les jours |
Uses authorised in Canada
A factor in maintaining healthy cartilage and/or joint health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur; in which case, discontinue use. Stop use if diarrhea, abdominal pain, heartburn, nausea or vomiting occur.
- Précautions et mises en garde
Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you are pregnant or breastfeeding. Consult a health care practitioner/health care provider/health care professional/doctor/physician prior to use if you have gallstones, bile duct obstruction, stomach ulcers or excess stomach acid. Consult a health care practitioner/health care provider/health care professional/doctor/ physician if symptoms persist or worsen. Consult a health care practitioner/health care provider/health care professional/doctor/ physician if you are pregnant or have diabetes.
Source
Official Health Canada record, licence 80096190
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.